Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel N Wolfe

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
The Journal of Infectious Diseases|October 24, 2007
Delayed role of tumor necrosis factor- alpha in overcoming the effects of pertussis toxinDaniel N Wolfe, Paul B Mann, Anne M Buboltz, et al.
Infection and Immunity|June 27, 2007
Comparative role of immunoglobulin A in protective immunity against the BordetellaeDaniel N Wolfe, Girish S Kirimanjeswara, Elizabeth M Goebel, et al.
Vaccine|December 5, 2017
Progress towards a vaccine against Ebola to meet emergency medical countermeasure needsDaniel N Wolfe, Amanda G Zarrabian, Gary L Disbrow, et al.
Vaccines|June 28, 2023
Developing Vaccines to Improve Preparedness for Filovirus Outbreaks: The Perspective of the USA Biomedical Advanced Research and Development Authority (BARDA)Lindsay A Parish, Eric J Stavale, Christopher R Houchens, et al.
Infection and Immunity|February 21, 2008
O antigen protects Bordetella parapertussis from complementElizabeth M Goebel, Daniel N Wolfe, Kelly Elder, et al.
Infection and Immunity|August 19, 2007
The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunityDaniel N Wolfe, Elizabeth M Goebel, Ottar N Bjornstad, et al.
Microbes and Infection|February 24, 2007
Different mechanisms of vaccine-induced and infection-induced immunity to Bordetella bronchisepticaLakshmi Gopinathan, Girish S Kirimanjeswara, Daniel N Wolfe, et al.
Vaccines|January 24, 2025
Strategic and Technical Considerations in Manufacturing Viral Vector Vaccines for the Biomedical Advanced Research and Development Authority ThreatsLindsay A Parish, Shyam Rele, Kimberly A Hofmeyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 2010
IL-10 induction by Bordetella parapertussis limits a protective IFN-gamma responseDaniel N Wolfe, Alexia T Karanikas, Sara E Hester, et al.
Human Vaccines & Immunotherapeutics|April 13, 2022
Partnering on vaccines to counter multi-drug resistant threats: Workshop proceedings, Biomedical Advanced Research and Development AuthorityJulie N Bergmann, Rushyannah R Killen-Cade, Lindsay A Parish, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
The Journal of Infectious Diseases|October 24, 2007
Delayed role of tumor necrosis factor- alpha in overcoming the effects of pertussis toxinDaniel N Wolfe, Paul B Mann, Anne M Buboltz, et al.
Infection and Immunity|June 27, 2007
Comparative role of immunoglobulin A in protective immunity against the BordetellaeDaniel N Wolfe, Girish S Kirimanjeswara, Elizabeth M Goebel, et al.
Vaccine|December 5, 2017
Progress towards a vaccine against Ebola to meet emergency medical countermeasure needsDaniel N Wolfe, Amanda G Zarrabian, Gary L Disbrow, et al.
Vaccines|June 28, 2023
Developing Vaccines to Improve Preparedness for Filovirus Outbreaks: The Perspective of the USA Biomedical Advanced Research and Development Authority (BARDA)Lindsay A Parish, Eric J Stavale, Christopher R Houchens, et al.
Infection and Immunity|February 21, 2008
O antigen protects Bordetella parapertussis from complementElizabeth M Goebel, Daniel N Wolfe, Kelly Elder, et al.
Infection and Immunity|August 19, 2007
The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunityDaniel N Wolfe, Elizabeth M Goebel, Ottar N Bjornstad, et al.
Microbes and Infection|February 24, 2007
Different mechanisms of vaccine-induced and infection-induced immunity to Bordetella bronchisepticaLakshmi Gopinathan, Girish S Kirimanjeswara, Daniel N Wolfe, et al.
Vaccines|January 24, 2025
Strategic and Technical Considerations in Manufacturing Viral Vector Vaccines for the Biomedical Advanced Research and Development Authority ThreatsLindsay A Parish, Shyam Rele, Kimberly A Hofmeyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 2010
IL-10 induction by Bordetella parapertussis limits a protective IFN-gamma responseDaniel N Wolfe, Alexia T Karanikas, Sara E Hester, et al.
Human Vaccines & Immunotherapeutics|April 13, 2022
Partnering on vaccines to counter multi-drug resistant threats: Workshop proceedings, Biomedical Advanced Research and Development AuthorityJulie N Bergmann, Rushyannah R Killen-Cade, Lindsay A Parish, et al.
Pageof 4